Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 1310/DELNP/2013
Who filed: DNP+ and I-MAK
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 21-07-2018
Patent type: Molecules

Click within the document, or manually enter the page number below

Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir (GS7977) , (3658/KOLNP/2009 (IN491013))

Countries: India Date: 2013
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2014
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (3999/CHENP/2012 (PCT/US2010/055045))

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Daclatasvir , (806/DELNP/2010 (PCT/US2008/071734))

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (9149/CHENP/2012)

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Glecaprevir, (2891/DELNP/2013)

Countries: India Date: 2019

Dnp+ And I Mak Opposition, Pibrentasvir, (1310/Delnp/2013)